Gene: MPND
Official Full Name: MPN domain containingprovided by HGNC
Gene Summary: Predicted to enable metallopeptidase activity and polyubiquitin modification-dependent protein binding activity. Predicted to be involved in double-strand break repair. Predicted to be part of BRCA1-A complex and BRISC complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01942 | MPND Knockout cell line (HeLa) | Human | MPND | 1:3~1:6 | Negative | Online Inquiry |
KO01943 | MPND Knockout cell line (HCT 116) | Human | MPND | 1:2~1:4 | Negative | Online Inquiry |
KO01944 | MPND Knockout cell line (HEK293) | Human | MPND | 1:3~1:6 | Negative | Online Inquiry |
KO01945 | MPND Knockout cell line (A549) | Human | MPND | 1:3~1:4 | Negative | Online Inquiry |
MPND Gene Knockout Cell Lines are precisely engineered cellular models designed to facilitate the comprehensive study of the MPND gene, integral to various biological processes including cell signaling, metabolism, and cellular stress responses. By utilizing CRISPR-Cas9 technology, these cell lines exhibit a complete absence of MPND gene expression, allowing researchers to elucidate the gene's specific roles and interactions within cellular pathways.
The primary function of MPND Gene Knockout Cell Lines revolves around their ability to provide a clear comparison between normal and MPND-deficient cells. This allows for the investigation of gene function, the identification of downstream signaling effects, and the assessment of potential compensatory mechanisms that may arise from gene loss. In essence, researchers can utilize these models to better understand the implications of MPND dysregulation in various pathophysiological contexts, such as cancer, neurodegenerative diseases, and metabolic disorders.
Scientifically, MPND Gene Knockout Cell Lines are crucial for advancing our knowledge in both basic and applied research settings. Their applications range from drug discovery and development to genetic research, providing a robust tool for elucidating disease mechanisms and identifying therapeutic targets. This specificity makes them invaluable in developing precision medicine strategies and validating potential clinical applications.
What sets MPND Gene Knockout Cell Lines apart from alternative models is their high specificity and reproducibility. Unlike traditional knockdown models, which may retain residual gene expression, these knockout cell lines ensure that researchers can confidently attribute any observed phenotypic changes directly to the absence of the MPND gene. Furthermore, they are robustly validated for quality and performance, ensuring researchers receive consistent and reliable results.
For researchers and clinicians, MPND Gene Knockout Cell Lines offer a unique opportunity to dissect the complexities of gene function and its implications in health and disease. By providing a streamlined and efficient model system, our product empowers the scientific community to accelerate their research initiatives.
Backed by years of expertise in genetic engineering and cellular biology, our company is committed to delivering high-quality biological products that drive innovation and discovery in the life sciences, making MPND Gene Knockout Cell Lines a trusted asset for professionals dedicated to advancing research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.